Successful Treatment of Recurrent Clostridioides difficile Infection Using a Novel, Drinkable, Oral Formulation of Fecal Microbiota.

Michael J SadowskyMichael MatsonPrince P MathaiMaradi PhoChristopher StaleyClayton EvertMelissa WeldyAlexander Khoruts

Published in: Digestive diseases and sciences (2024)

We developed a novel organoleptically acceptable liquid formulation of fecal microbiota that is suitable for use in clinical trials for patients with difficulties in swallowing capsules.

Keyphrases

clinical trial
clostridium difficile
drug delivery
ionic liquid
phase ii
randomized controlled trial
open label
study protocol
phase iii